Emel Karaali's profile picture

Emel Karaali

Project Manager at Evidera

Emel Karaali is a seasoned project manager with extensive experience in healthcare and service delivery. Currently serving at Evidera since June 2022, Karaali previously held the position of program manager at C3i Healthcare Connections, where responsibilities included overseeing the implementation of new services and managing client communications. With a strong background in operations within C3i Europe, encompassing roles from assistant operations manager to subject matter expert, Karaali has demonstrated expertise in project management, quality assurance, and team leadership. Educational qualifications include a Master's in Business Administration from the University of National and World Economy, a C1 certificate in German from Goethe Institut, a Bachelor's in Translation from the University of Veliko Turnovo, and a high school diploma in English.

Links


Org chart

Upgrade to view 0 reports



Offices

This person is not in any offices


E

Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.